1-(Methylsulfonyl)spiro[indoline-3,4'-piperidine]

Catalog No. :
ACHCXZ542
CAS No. :
178261-41-1
Molecular Formula :
C13H18N2O2S
Molecular Weight :
266.37

IUPAC Name:1-(methylsulfonyl)spiro[indoline-3,4'-piperidine]

1-(Methylsulfonyl)spiro[indoline-3,4'-piperidine] structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$432.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(Methylsulfonyl)spiro[indoline-3,4'-piperidine]
IUPAC Name1-(methylsulfonyl)spiro[indoline-3,4'-piperidine]
MDL No.MFCD04108105
Molecular FormulaC13H18N2O2S
Molecular Weight266.37
SMILESCS(=O)(=O)N1CC2(CCNCC2)C2=C1C=CC=C2
InChI KeyNSECJXCOETXUHS-UHFFFAOYSA-N
Synonym1-(methylsulfonyl)spiro[indoline-3,4'-piperidine];1,2-dihydro-1-(methylsulfonyl)-Spiro[3H-indole-3,4'-piperidine];Spiro[3H-indole-3,4'-piperidine], 1,2-dihydro-1-(methylsulfonyl)-;1-methylsulfonylspiro[2H-indole-3,4'-piperidine];1-(methylsulfonyl)spiro[indoline-3,4'-piperidine] Synonyms: intermediate of MK677;1-Methylsulfonyl-spiro[indoline-3,4'-piperidine] HCl;1-(methylsulfonyl)spiro[indoline-3,4'-piperidine;1-(methylsulfonyl)spiro[indoline-3
CAS No.178261-41-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACHCXZ542 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHCXZ542 route product structure diagram
    ACHCXZ542178261-41-1
Inquiry

2. ACHCXZ542 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHCXZ542 route product structure diagram
    ACHCXZ542178261-41-1
Inquiry

Comments (0)